Copyright
©The Author(s) 2024.
World J Diabetes. May 15, 2024; 15(5): 898-913
Published online May 15, 2024. doi: 10.4239/wjd.v15.i5.898
Published online May 15, 2024. doi: 10.4239/wjd.v15.i5.898
Figure 1 The flow diagram depicts the incorporation and distribution of the study cohort.
T2DM: Type 2 diabetes mellitus; HC: Healthy control; NAFLD: Non-alcoholic fatty liver disease; F0-1: No or mild clinically fibrosis with fibrosis 4 score (FIB-4) < 1.3; F2-4: Clinically significant fibrosis with FIB-4 ≥ 1.3; BAs: Bile acids; UFAs: Unsaturated fatty acids.
- Citation: Feng SS, Wang SJ, Guo L, Ma PP, Ye XL, Pan ML, Hang B, Mao JH, Snijders AM, Lu YB, Ding DF. Serum bile acid and unsaturated fatty acid profiles of non-alcoholic fatty liver disease in type 2 diabetic patients. World J Diabetes 2024; 15(5): 898-913
- URL: https://www.wjgnet.com/1948-9358/full/v15/i5/898.htm
- DOI: https://dx.doi.org/10.4239/wjd.v15.i5.898